Capricor Therapeutics Inc Hope 3 Top Line Data Call Transcript
Good morning ladies and gentlemen, and welcome to the Capricor Therapeutics HOPE-3 Phase 3 top-line data call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session.
(Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to our host, Mr. AJ Bergmann, Capricor's Chief Financial Officer. Please go ahead.
Thank you and good morning, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. Statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future R&D plans, including their anticipated conduct and timing of pre-clinical and clinical studies, our enrollment in patients in our clinical studies, our plans to present or report additional data.
Our plans regarding regulatory
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

